Atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of atomoxetine. Atomoxetine is a selective norepinephrine re-uptake inhibitor. It appears to work by blocking or slowing the reabsorption of norepinephrine...
Strattera (atomoxetine hcl) is approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 and older, teens, and adults. Strattera should be used as part of a total treatment program for ADHD that may include counseling or other therapies...
A vast amount of data has been analyzed as part of the Global Burden Of Disease 2015, providing importantl information on illness and disease worldwide.
The first ever analysis of men conceived though intracytoplasmic sperm injection reveals the procedure may be linked to poorer sperm count and quality.
Women may be at risk of remaining undiagnosed of Alzheimer's disease until more advanced stages of the condition due to their better verbal memory skills.